Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Lith-O-Asp

Copy Product Info
😃Good
Catalog No. T11858Cas No. 881179-02-8

Lith-O-Asp is a sialytransferase (ST) inhibitor with IC50 values ranging from 12 to 37 μM.

Lith-O-Asp

Lith-O-Asp

Copy Product Info
😃Good
Catalog No. T11858Cas No. 881179-02-8
Lith-O-Asp is a sialytransferase (ST) inhibitor with IC50 values ranging from 12 to 37 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$5236-8 weeks6-8 weeks
25 mg$1,5206-8 weeks6-8 weeks
50 mg$1,9806-8 weeks6-8 weeks
100 mg$2,5006-8 weeks6-8 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Lith-O-Asp is a sialytransferase (ST) inhibitor with IC50 values ranging from 12 to 37 μM.
Targets&IC50
ST:12-37 μM
In vitro
The results indicate that Lith-O-Asp reduces the activity of both a-2,3- and a-2,6-sialyltransferases, consequently inhibiting the transfer of sialic acids to target glycoproteins[1]. Despite showing no significant growth inhibition effect on various cancer cell lines at doses of 10, 30, and 60 μM, in vitro assays reveal Lith-O-Asp's capability to suppress the activities of ST3Gal I, ST3Gal III, and ST6GalI, with IC50 values ranging from 12 to 37 μM. Furthermore, flow cytometry analysis demonstrates a marked decrease in the expression of cell surface a-2,3- and a-2,6-sialylated antigens.
In vivo
In lung tissues of mice treated with DMSO and observed using the IVIS in vivo imaging system, a significant presence of secondary metastatic cancer cells was noted 26 days post-fat pad inoculation. Conversely, mice treated with Lith-O-Asp exhibited a reduction in lung metastases, with only 3 of 8 mice showing any metastasis compared to all DMSO-treated mice. The average number of tumor nodules per mouse in the DMSO group was 11±9, while in the Lith-O-Asp group, it was significantly lower at 2±4 nodules. Additionally, 4T1-Luc illumination signals, indicating tumor presence, were markedly stronger in the DMSO control group than in the Lith-O-Asp-treated group on days 7 and 9[1].
Chemical Properties
Molecular Weight491.66
FormulaC28H45NO6
Cas No.881179-02-8
Smiles[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)[C@@H](N)CC(O)=O)[C@H](C)CCC(O)=O
Relative Density.1.19 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 106 mg/mL (215.6 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0339 mL10.1696 mL20.3393 mL101.6963 mL
5 mM0.4068 mL2.0339 mL4.0679 mL20.3393 mL
10 mM0.2034 mL1.0170 mL2.0339 mL10.1696 mL
20 mM0.1017 mL0.5085 mL1.0170 mL5.0848 mL
50 mM0.0407 mL0.2034 mL0.4068 mL2.0339 mL
100 mM0.0203 mL0.1017 mL0.2034 mL1.0170 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Lith-O-Asp | purchase Lith-O-Asp | Lith-O-Asp cost | order Lith-O-Asp | Lith-O-Asp chemical structure | Lith-O-Asp in vivo | Lith-O-Asp in vitro | Lith-O-Asp formula | Lith-O-Asp molecular weight